Related Experiment Video
Updated: May 18, 2026
12:22
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Tailor-made renal cell carcinoma vaccines
1Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA. glenn_dranoff@dfci.harvard.edu
Cancer Cell
|September 15, 2012
Summary
New peptide vaccines show promise in advanced kidney cancer, offering insights into antigen selection and immune response monitoring for cancer vaccine development.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Cancer vaccines are emerging as a clinical strategy with demonstrated activity.
- Significant challenges persist in optimizing cancer vaccine development, including antigen selection, immune stimulation, patient stratification, and response monitoring.
Purpose of the Study:
- To investigate the clinical activity of peptide vaccines in patients with advanced renal cell carcinoma.
- To gain insights into critical aspects of cancer vaccine design and implementation.
Main Methods:
- A study involving advanced renal cell carcinoma patients treated with peptide vaccines.
- Evaluation of clinical responses and immune parameters.
Main Results:
- The study provides crucial data on the efficacy and immunological impact of peptide vaccines in this patient cohort.
- Key insights were generated regarding antigen selection and immune stimulation strategies.
Conclusions:
- Peptide vaccines demonstrate potential in treating advanced renal cell carcinoma.
- The findings contribute to addressing uncertainties in cancer vaccine development and patient management.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...